| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Mersana Therapeutics Inc (NASDAQ: MRSN)
MRSN Technical Analysis
5
| As on 13th Nov 2025 MRSN SHARE Price closed @ 27.43 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.45 & Strong Buy for SHORT-TERM with Stoploss of 1.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRSNSHARE Price
| Open | 27.68 | Change | Price | % |
| High | 28.07 | 1 Day | 18.56 | 209.24 |
| Low | 26.55 | 1 Week | 19.27 | 236.15 |
| Close | 27.43 | 1 Month | 19.43 | 242.88 |
| Volume | 3140125 | 1 Year | 25.03 | 1042.92 |
| 52 Week High 10.59 | 52 Week Low 0.26 | ||||
NASDAQ USA Most Active Stocks
| NVVE | 0.48 | 200.00% |
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| ONDS | 6.56 | 19.06% |
| NVDA | 186.86 | -3.58% |
| OPEN | 8.56 | -8.64% |
| LMDX | 0.02 | 0.00% |
| TSLA | 401.99 | -6.64% |
| PLUG | 2.49 | -8.79% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MRSN Daily Charts |
MRSN Intraday Charts |
Whats New @ Bazaartrend |
MRSN Free Analysis |
|
|
MRSN Important Levels Intraday
| RESISTANCE | 30.36 |
| RESISTANCE | 29.42 |
| RESISTANCE | 28.84 |
| RESISTANCE | 28.26 |
| SUPPORT | 26.60 |
| SUPPORT | 26.02 |
| SUPPORT | 25.44 |
| SUPPORT | 24.50 |
MRSN Forecast November 2025
| 4th UP Forecast | 28.45 |
| 3rd UP Forecast | 28.12 |
| 2nd UP Forecast | 27.92 |
| 1st UP Forecast | 27.72 |
| 1st DOWN Forecast | 27.14 |
| 2nd DOWN Forecast | 26.94 |
| 3rd DOWN Forecast | 26.74 |
| 4th DOWN Forecast | 26.41 |
MRSN Weekly Forecast
| 4th UP Forecast | 27.97 |
| 3rd UP Forecast | 27.80 |
| 2nd UP Forecast | 27.69 |
| 1st UP Forecast | 27.58 |
| 1st DOWN Forecast | 27.28 |
| 2nd DOWN Forecast | 27.17 |
| 3rd DOWN Forecast | 27.06 |
| 4th DOWN Forecast | 26.89 |
MRSN Forecast2025
| 4th UP Forecast | 81.02 |
| 3rd UP Forecast | 63.83 |
| 2nd UP Forecast | 53.21 |
| 1st UP Forecast | 42.59 |
| 1st DOWN Forecast | 12.27 |
| 2nd DOWN Forecast | 1.65 |
| 3rd DOWN Forecast | -8.97 |
| 4th DOWN Forecast | -26.16 |
Mersana Therapeutics Inc ( NASDAQ USA Symbol : MRSN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRSN Business Profile
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development of antibody drug conjugates (ADC) for cancer patients with unmet need. The company develops XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients with ovarian cancer and non-small cell lung cancer (NSCLC) adenocarcinoma; and XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumors, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. It also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. The company has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts. Address: 840 Memorial Drive, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service